Experian Ranked 6th in 2025 IDC FinTech Rankings: Top 100
Experian today announced that it was ranked 6th in the 2025 IDC FinTech Rankings: Top 100, rising one spot from last year’s rankings and placing in the top-10 global technology providers for the fourth consecutive year. The FinTech Rankings feature enterprise companies from around the world that serve multiple industries and generate significant revenues from the financial services and FinTech industries.
“Experian helps financial services organizations tackle their toughest business challenges by delivering continuous innovation in AI decisioning, advanced analytics, and fraud prevention,” said Alex Lintner, CEO of Experian Technology & Software. “As one of the world’s largest FinTech companies, this recognition underscores how we empower customers globally to accelerate operations, expand financial inclusion, reduce risk with transformative AI, and ultimately drive stronger business results.”
A prime example of how Experian helps its financial services customers replace manual processes with automation and accelerate time-to-market is its recent announcement of Experian Assistant for Model Risk Management, an AI-driven solution that enables financial institutions to govern and manage models more efficiently across the entire model‑development lifecycle. Fully integrated with the Experian Ascend PlatformTM, the solution helps speed model validation, improve auditability and transparency, and reduce regulatory and reputational risk.
“We congratulate Experian for being ranked 6th in the 2025 IDC FinTech rankings,” said Marc DeCastro research director at IDC. “Recognition in the top 10 of the IDC FinTech rankings demonstrates Experian’s commitment to bringing the innovation necessary around areas like AI to keep the financial service industry at the forefront of providing modern digital experiences, technologies and platforms in the industry ecosystem.”
The Fortune 500-style ranking evaluates the top global providers of financial technology based on calendar year revenues from financial institutions for hardware, software and/or services. The IDC FinTech Rankings: Top 100 represents those organizations that are committed to helping financial services companies successfully implement their digital transformation initiatives for the betterment of their customers around the world. For more information about the rankings, visit https://www.idc.com/research/industry/fintech-rankings.
About Experian
Experian is a global data and technology company, powering opportunities for people and businesses around the world. We help to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics and software. We also assist millions of people to realize their financial goals and help them to save time and money.
We operate across a range of markets, from financial services to healthcare, automotive, agrifinance, insurance, and many more industry segments.
We invest in talented people and new advanced technologies to unlock the power of data and innovate. As a FTSE 100 Index company listed on the London Stock Exchange (EXPN), we have a team of 25,200 people across 32 countries. Our corporate headquarters are in Dublin, Ireland. Learn more at experianplc.com.
Experian and the Experian marks used herein are trademarks or registered trademarks of Experian and its affiliates. Other product and company names mentioned herein are the property of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250908020799/en/
Contacts
Michael Troncale
Experian Public Relations
+1 714 830 5462
michael.troncale@experian.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Owlet Makes Premium Monitoring Possible for Every Family With New Dream Sight™ Video Monitor9.9.2025 14:45:00 EEST | Press release
Owlet, Inc. (NYSE: OWLT) (the “Company” or “Owlet”), the pioneer of smart infant monitoring, announces the launch of its new HD video baby monitor, Dream Sight™, and next-generation Dream Duo™. These products represent an important step for Owlet in the category, featuring advanced technology designed to provide clarity, connection, and peace of mind from day one. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250909618049/en/ Owlet's Dream Sight 2K HD Video Monitor. “Parents are clear about what they need in a baby monitor – more advanced features, greater reliability, deeper security, and a price point that makes sense,” said Kurt Workman, Owlet’s Chief Executive Officer and Co-Founder. “Dream Sight is a direct response to that feedback from our customers. When paired with our medically-certified Dream Sock®, it creates a connected monitoring experience that gives caregivers the confidence and peace of mind they need.” Int
France Grants Reimbursed Compassionate Access (AAC) for Agenus’ BOT/BAL in Refractory MSS Metastatic Colorectal Cancer9.9.2025 14:43:00 EEST | Press release
Agenus Inc. (Nasdaq: AGEN), a leader in immuno‑oncology, today announced its investigational combination botensilimab plus balstilimab (BOT/BAL) is now available to eligible patients with refractory microsatellite‑stable (MSS) metastatic colorectal cancer (mCRC) under France’s compassionate access (Accès compassionnel, or AAC) framework. The French National Agency of Medicines and Health Products Safety’s (ANSM) listings for botensilimab and balstilimab are live and detail eligibility (including MSS and no active liver metastases) and dosing. BOT/BAL remains investigational and is not approved for commercial marketing in France or elsewhere. How AAC reimbursement works Once the ANSM authorizes AAC, hospital use is covered 100% by Assurance Maladie. Hospitals are reimbursed at the invoiced purchase price (TTC), outside the Diagnosis-related Group (DRG), referred to in France as “en sus du GHS”. During AAC the manufacturer either provides the medicine free of charge or invoices an “indem
Promega and Watchmaker Genomics Announce Strategic Partnership to Advance Molecular Analysis with Next-Generation Reverse Transcriptase9.9.2025 14:11:00 EEST | Press release
Promega Corporation has entered a strategic partnership with Watchmaker Genomics to license a novel engineered reverse transcriptase. Designed for enhanced accuracy and sensitivity in RNA analysis, the enzyme will enhance Promega capabilities to manufacture and deliver both catalog and customized solutions for clinical, applied and pharmaceutical molecular applications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250908209296/en/ “Watchmaker’s enzyme offers a combination of attributes that establish a new benchmark for reverse transcriptase performance,” says Sara Mann, VP of Commercial Excellence at Promega. “By incorporating it into our portfolio, we are giving customers a powerful tool for improved accuracy and enhanced sensitivity of RNA-based assays.” This partnership marks the beginning of an expanded collaboration between Watchmaker Genomics and Promega, with both companies committed to developing next-generation e
Kinaxis Powers Shimadzu’s Supply Chain Advancement for the Modern Manufacturing Era9.9.2025 14:00:00 EEST | Press release
Kinaxis® (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced that Shimadzu Corporation, a top manufacturer of high-technology precision instruments, has selected the Kinaxis Maestro® platform to advance its supply chain strategy and outmaneuver global trade volatility. Shimadzu is turning to Maestro to simulate real-world trade scenarios, align cross-functional teams and proactively act before disruption hits. Shimadzu makes precision equipment for high-stakes industries from pharmaceuticals to aerospace where speed and foresight are critical. As they expand globally, Shimadzu needed a supply chain technology platform that could process complex data, provide instant optionality and protect profits as it navigates a dynamic global tariff and trade environment. “We have built our reputation on precision, innovation and excellence for our partners,” said Akira Okubo, corporate officer, general manager, DX・IT strategy management department at Shimadzu Corpo
IFF launches interactive platform to inspire adult beverage innovation9.9.2025 14:00:00 EEST | Press release
IFF (NYSE: IFF), a global leader in food, beverage, health and wellness, has unveiled SipScape, a new platform designed to inspire innovation across the rapidly evolving adult beverage landscape. It offers actionable insights and trends, including product design, flavor modulation and sweetness reduction in no-and low-alcohol beverages. The platform also highlights IFF’s expertise in incorporating botanicals, natural colors and other functional additions based on current trends and market demands. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250909611189/en/ Photo credit: IFF “Understanding how and why people drink today is essential to staying ahead,” said Fernanda De Paula, vice president of global beverages category for IFF Taste. “Consumers are looking for more than a buzz, and drinks are no longer defined solely by their alcohol content. The most successful new products are those that reflect people’s values, fulfill
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom